Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1995 Jun;76(3):191–199.

Different effect of cyclosporin A on arthritides induced by a muramyl dipeptide analogue or the complete adjuvant in rats.

T Sugawara 1, S Takada 1, K Furuhama 1, S Takayama 1, M Nomura 1, M Kato 1
PMCID: PMC1997172  PMID: 7547430

Abstract

Muramyl dipeptide-Lys(L18) given by daily subcutaneous injection for 14 days induced arthritis in male Lewis, Fischer and nude rats, to a lesser degree in the last two than in the first strain. On the other hand, a single intradermal administration of Freund's complete adjuvant induced arthritis in Lewis and Fischer but not nude rats. Cyclosporin A (CsA) co-administered for 14 days markedly exacerbated the muramyl dipeptide-Lys(L18) induced arthritis (MIA) in rats of all three strains, but completely blocked the development of the adjuvant induced arthritis (AIA) in Lewis rats. Furthermore, AIA was transferred to recipient Lewis rats through spleen cells obtained from the donors with AIA, whereas MIA was not. Antibodies against type II collagen and DNA were not detected in sera from MIA or AIA rats. These data show a clear difference between MIA and AIA in the pattern of development of arthritis and suggest that delayed hypersensitivity reactions may be involved in the pathogenetic mechanisms of AIA, but not in MIA.

Full text

PDF
191

Images in this article

193Figure 2
on p.193
194Figure 3
on p.194
194Figure 4
on p.194
195Figure 5
on p.195
195Figure 6
on p.195
196Figure 7
on p.196

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akahane K., Yamaguchi F., Kita Y., Une T., Osada Y. Stimulation of macrophages by muroctasin to produce colony-stimulating factors. Arzneimittelforschung. 1990 Feb;40(2 Pt 1):179–183. [PubMed] [Google Scholar]
  2. Akasaki M., Masayasu H., Tsukada W., Takegoshi T. Specific binding sites of muroctasin on murine macrophages. Arzneimittelforschung. 1988 Jul;38(7A):978–980. [PubMed] [Google Scholar]
  3. Akasaki M., Takashi T., Kita Y., Tsukada W. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18). Agents Actions. 1987 Oct;22(1-2):144–150. doi: 10.1007/BF01968830. [DOI] [PubMed] [Google Scholar]
  4. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  5. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  6. Brideau R. J., Carter P. B., McMaster W. R., Mason D. W., Williams A. F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol. 1980 Aug;10(8):609–615. doi: 10.1002/eji.1830100807. [DOI] [PubMed] [Google Scholar]
  7. Chang Y. H., Pearson C. M., Chedid L. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. J Exp Med. 1981 Apr 1;153(4):1021–1026. doi: 10.1084/jem.153.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clague R. B., Morgan K., Shaw M. J., Holt P. J. Native type II collagen-induced arthritis in the rat. II. Relationship between the humoral immune response to native type II collagen and arthritis. J Rheumatol. 1980 Nov-Dec;7(6):775–782. [PubMed] [Google Scholar]
  9. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  10. Griffiths M. M., DeWitt C. W. Genetic control of collagen-induced arthritis in rats: the immune response to type II collagen among susceptible and resistant strains and evidence for multiple gene control. J Immunol. 1984 Jun;132(6):2830–2836. [PubMed] [Google Scholar]
  11. Griffiths M. M., Eichwald E. J., Martin J. H., Smith C. B., DeWitt C. W. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 1981 Jun;24(6):781–789. doi: 10.1002/art.1780240605. [DOI] [PubMed] [Google Scholar]
  12. Hang L., Theofilopoulos A. N., Dixon F. J. A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med. 1982 Jun 1;155(6):1690–1701. doi: 10.1084/jem.155.6.1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Koga T., Sakamoto S., Onoue K., Kotani S., Sumiyoshi A. Efficient induction of collagen arthritis by the use of a synthetic muramyl dipeptide. Arthritis Rheum. 1980 Sep;23(9):993–997. doi: 10.1002/art.1780230905. [DOI] [PubMed] [Google Scholar]
  14. Kohashi O., Aihara K., Ozawa A., Kotani S., Azuma I. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats. Lab Invest. 1982 Jul;47(1):27–36. [PubMed] [Google Scholar]
  15. Kohashi O., Kohashi Y., Shigematsu N., Ozawa A., Kotani S. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Lab Invest. 1986 Sep;55(3):337–346. [PubMed] [Google Scholar]
  16. Mason D. W., Arthur R. P., Dallman M. J., Green J. R., Spickett G. P., Thomas M. L. Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev. 1983;74:57–82. doi: 10.1111/j.1600-065x.1983.tb01084.x. [DOI] [PubMed] [Google Scholar]
  17. Nagao S., Tanaka A. Muramyl dipeptide-induced adjuvant arthritis. Infect Immun. 1980 May;28(2):624–626. doi: 10.1128/iai.28.2.624-626.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nakajima R., Ishida Y., Yamaguchi F., Otani T., Ono Y., Nomura M., Une T., Osada Y. Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice. Arzneimittelforschung. 1988 Jul;38(7A):986–992. [PubMed] [Google Scholar]
  19. Nakajima R., Yshida Y., Akahane K., Sekiguchi M., Osada Y. Stimulatory effect of romurtide on hematopoiesis in monkeys. Arzneimittelforschung. 1991 Jan;41(1):60–65. [PubMed] [Google Scholar]
  20. PEARSON C. M. EXPERIMENTAL JOINT DISEASE OBSERVATIONS ON ADJUVANT-INDUCED ARTHRITIS. J Chronic Dis. 1963 Aug;16:863–874. doi: 10.1016/0021-9681(63)90136-x. [DOI] [PubMed] [Google Scholar]
  21. PEARSON C. M., WOOD F. D. PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS. J Exp Med. 1964 Oct 1;120:547–560. doi: 10.1084/jem.120.4.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sfaksi A., Bonneville M., Soulillou J. P. Cellular immune response in rnu/rnu rats. I. Lectin responsiveness and IL-2 production kinetics of natural cytotoxicity and spleen-cell surface marker expression. Immunology. 1985 Aug;55(4):655–662. [PMC free article] [PubMed] [Google Scholar]
  23. Shimoda K., Okamura S., Harada N., Omori F., Niho Y. Production of interleukin-6 from macrophages by MDP-Lys (L 18), romurtide. Res Commun Chem Pathol Pharmacol. 1990 Dec;70(3):289–296. [PubMed] [Google Scholar]
  24. Shimoda K., Okamura S., Kawasaki C., Omori F., Matsuguchi T., Niho Y. Muroctasin [MDP-Lys(18)] augments the production of granulocyte colony-stimulating factor (G-CSF) from human peripheral blood mononuclear cells in vitro. Int J Immunopharmacol. 1990;12(7):729–736. doi: 10.1016/0192-0561(90)90035-l. [DOI] [PubMed] [Google Scholar]
  25. Sternberg E. M., Hill J. M., Chrousos G. P., Kamilaris T., Listwak S. J., Gold P. W., Wilder R. L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2374–2378. doi: 10.1073/pnas.86.7.2374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sternberg E. M., Young W. S., 3rd, Bernardini R., Calogero A. E., Chrousos G. P., Gold P. W., Wilder R. L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4771–4775. doi: 10.1073/pnas.86.12.4771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sugawara T., Kato M., Furuhama K., Takada S., Takayama S. Pharmacological aspects of arthritis induced by a muramyl dipeptide analogue in rats. Eur J Pharmacol. 1992 Sep 1;228(2-3):147–153. doi: 10.1016/0926-6917(92)90024-7. [DOI] [PubMed] [Google Scholar]
  29. Sugawara T., Kato M., Takayama S. Arthritis and hematological changes induced by an analogue of muramyl dipeptide in rats. Fundam Appl Toxicol. 1992 Apr;18(3):395–404. doi: 10.1016/0272-0590(92)90138-8. [DOI] [PubMed] [Google Scholar]
  30. Taurog J. D., Sandberg G. P., Mahowald M. L. The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient. Cell Immunol. 1983 Feb 1;75(2):271–282. doi: 10.1016/0008-8749(83)90325-8. [DOI] [PubMed] [Google Scholar]
  31. Tsubura E., Nomura T., Niitani H., Osamura S., Okawa T., Tanaka M., Ota K., Nishikawa H., Masaoka T., Fukuoka M. Restorative activity of muroctasin on leukopenia associated with anticancer treatment. Arzneimittelforschung. 1988 Jul;38(7A):1070–1074. [PubMed] [Google Scholar]
  32. WAKSMAN B. H., PEARSON C. M., SHARP J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol. 1960 Oct;85:403–417. [PubMed] [Google Scholar]
  33. Wilder R. L., Calandra G. B., Garvin A. J., Wright K. D., Hansen C. T. Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum. 1982 Sep;25(9):1064–1072. doi: 10.1002/art.1780250906. [DOI] [PubMed] [Google Scholar]
  34. Zídek Z., Maśek K., Jiricka Z. Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide. Infect Immun. 1982 Feb;35(2):674–679. doi: 10.1128/iai.35.2.674-679.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A., Cohen I. R. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5117–5120. doi: 10.1073/pnas.82.15.5117. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES